[The changes and effects of metalloproteinase-2 and tissue inhibitors of metalloproteinase-1 protein and mRNA expression in the lung tissue of neonatal rats with chronic lung disease induced by hyperoxia].
OBJECTIVE
To investigate the dynamic changes and the effects of metalloproteinase-2 (MMP-2) and tissue inhibitors of metalloproteinase-2 (TIMP-2) mRNA in lungs of neonatal rats after inhaling high concentration of oxygen.


METHODS
Full-term newborn rats were continuously exposed to oxygen (0.90-0.95) or room air (0.21O(2)) within 12 hours after birth. Lung histological study with hematoxylin-eosin staining (HE) and radical alveolar counts (RAC) were performed; the changes in MMP-2 and TIMP-2 protein and mRNA expression were measured by immunohistochemistry and reverse transcription-polymerase chain reaction (RT-PCR) on 1, 3, 7, 14 and 21 days in hyperoxia groups and air inhalation controls.


RESULTS
Compared with air inhalation controls, inflammation response was seen in early stage, the arrest of lung development was evident after 7 days of oxygen exposure, finally resulting in interstitial fibrosis; RAC began to decrease from 7 days in hyperoxia rats compared to air inhalation controls (P<0.05), more so on 14 days and 21 days (both P<0.01); MMP-2 protein and mRNA expression were higher on 3 days (P<0.05 and P<0.01), and protein decreased on 14 days (P<0.05), while mRNA didn't change; the expression of TIMP-2 protein and mRNA showed no change all the time.


CONCLUSIONS
With prolonged hyperoxia, the balance of MMP-2/ TIMP-2 can not be maintained. Collagen breakdown is disturbed, which may lead to lung inflammatory injury in early stage and then collagen deposition in lung interstitium and lung development is arrested resulting in chronic lung disease.
Liu
Xue-Yan
XY
Department of Pediatrics, The Shengjing Affiliated Hospital, China Medical University, Shenyang 110004, Liaoning, China.
Xue
Xin-Dong
XD
D000818:Animals; D000831:Animals, Newborn; D004195:Disease Models, Animal; D018496:Hyperoxia / Q000150:complications* / Q000378:metabolism; D008168:Lung / Q000378:metabolism / Q000473:pathology; D008171:Lung Diseases / Q000209:etiology / Q000378:metabolism* / Q000473:pathology; D020778:Matrix Metalloproteinase 2 / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D011897:Random Allocation; D051381:Rats; D017208:Rats, Wistar; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000378:metabolism*
D012333:RNA, Messenger; D019715:Tissue Inhibitor of Metalloproteinase-1; D020778:Matrix Metalloproteinase 2; C522363:Mmp2 protein, rat